HC Wainwright & Co. Maintains Buy on Alimera Sciences, Raises Price Target to $6
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Yi Chen has maintained a Buy rating on Alimera Sciences (NASDAQ:ALIM) and increased the price target from $5 to $6.
March 08, 2024 | 6:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Alimera Sciences' Buy rating was maintained by HC Wainwright & Co., with the price target raised from $5 to $6.
The maintenance of a Buy rating combined with an increased price target typically signals analyst confidence in the company's future performance. This can positively influence investor sentiment and potentially lead to an increase in the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100